8-144514197-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_004260.4(RECQL4):c.1870G>A(p.Val624Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000114 in 1,612,144 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RECQL4 | NM_004260.4 | c.1870G>A | p.Val624Ile | missense_variant | 11/21 | ENST00000617875.6 | NP_004251.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.1870G>A | p.Val624Ile | missense_variant | 11/21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
RECQL4 | ENST00000621189.4 | c.799G>A | p.Val267Ile | missense_variant | 10/20 | 1 | ENSP00000483145.1 | |||
RECQL4 | ENST00000534626.6 | c.238G>A | p.Val80Ile | missense_variant | 2/8 | 5 | ENSP00000477457.1 | |||
RECQL4 | ENST00000532846.2 | c.724G>A | p.Val242Ile | missense_variant | 7/9 | 5 | ENSP00000476551.1 |
Frequencies
GnomAD3 genomes AF: 0.0000987 AC: 15AN: 152046Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000237 AC: 58AN: 244916Hom.: 1 AF XY: 0.000322 AC XY: 43AN XY: 133560
GnomAD4 exome AF: 0.000116 AC: 169AN: 1460098Hom.: 2 Cov.: 36 AF XY: 0.000178 AC XY: 129AN XY: 726334
GnomAD4 genome AF: 0.0000987 AC: 15AN: 152046Hom.: 0 Cov.: 34 AF XY: 0.000121 AC XY: 9AN XY: 74258
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Baller-Gerold syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at